Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 9/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.49 |
| ▸ | HNF4A | P41235 | 3/20 | 0.49 |
| ▸ | DHFR | P00374 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25724110 | 0.76 | ACMSD (0.70) | ACMSDMCL1HNF4ADHFRCA12 | |
| SCHEMBL25718037 | 0.76 | ACMSD (0.71) | ACMSDMCL1HNF4ADHFR | |
| SCHEMBL25838444 | 0.73 | ACMSD (0.47) | ACMSDMCL1HNF4ADHFRPTPN1 | |
| SCHEMBL28054694 | 0.72 | ALDH1A1 (0.50) | ACMSDHNF4AHSD17B10AKR1C3KDM4E | |
| SCHEMBL22088482 | 0.71 | PRKAB2 (0.56) | ACMSDMCL1HNF4ADHFRBACE1 | |
| SCHEMBL17384104 | 0.71 | HNF4A (0.68) | ACMSDHNF4APTPN1KDM4ECA12 | |
| SCHEMBL11086117 | 0.70 | BACE1 (0.61) | ACMSDMCL1HNF4ADHFRBACE1 | |
| SCHEMBL163610 | 0.70 | CA1 (0.59) | ACMSDMCL1HNF4ADHFRPTPN1 | |
| SCHEMBL2533617 | 0.69 | ACMSD (0.76) | ACMSDMCL1HNF4ADHFRPTPN1 | |
| SCHEMBL9249788 | 0.69 | CYP2C8 (0.57) | ACMSDMCL1HNF4ADHFRBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | C1R, C1S, C9 | ACMSD 2362/4885MCL1 2124/4885HNF4A 2682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.